Association between depressive symptoms, CD4 count and HIV viral suppression among HIV-HCV co-infected people

Wusiman Aibibula1, Joseph Cox1,2,3, Anne-Marie Hamelin1

  • 1a Department of Epidemiology, Biostatistics and Occupational Health , McGill University , Montreal , QC , Canada.

AIDS Care
|January 30, 2018
PubMed

Insights

Depressive symptoms increase the risk of detectable HIV viral load in people with HIV-HCV co-infection. Screening for depression may improve HIV viral suppression and reduce transmission.

Area of Science:

  • Medical research
  • Public health
  • Infectious diseases

Background:

  • Depressive symptoms negatively impact HIV viral control and immune recovery.
  • Previous research has not exclusively examined this link in HIV-Hepatitis C Virus (HCV) co-infection.
  • HIV-HCV co-infected individuals may be more vulnerable to depressive symptoms' health effects.

Purpose of the Study:

  • To assess the association between depressive symptoms and HIV viral load control.
  • To investigate the impact of depressive symptoms on CD4 count in HIV-HCV co-infected individuals.
  • To determine if depressive symptoms pose a risk for incomplete HIV viral suppression in this population.

Main Methods:

  • Utilized data from the Canadian Co-Infection Cohort (CCC) FS Sub-Study.
  • Employed a stabilized inverse probability weighted marginal structural model.
  • Analyzed data from 725 participants enrolled between 2012 and 2015.

Main Results:

  • 52% of participants reported depressive symptoms at baseline.
  • Individuals with depressive symptoms had a 1.32 times higher risk of detectable HIV viral load.
  • No significant difference in CD4 count was observed between those with and without depressive symptoms.

Conclusions:

  • Depressive symptoms are a risk factor for incomplete short-term HIV viral suppression in HIV-HCV co-infected individuals.
  • Screening for and counseling on depressive symptoms could enhance HIV health outcomes.
  • Intervention may contribute to reduced HIV transmission rates.

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.2K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
41.3K
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
481
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
935